U.S. Drug Manufacturers Stock News
Categories
- All
- Editor's Picks
- Stock Market News
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Instant Alerts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
GuruFocus Research Drug Manufacturers
ANI Pharmaceuticals Inc (ANIP) Q2 2024 Earnings Call Transcript Highlights: Record Revenue and Strategic Growth
ANI Pharmaceuticals Inc (ANIP) reports an 18% revenue increase and raises full-year guidance amid strong performance in rare disease and generics segments. Aug 09, 2024
GuruFocus Research Drug Manufacturers
Eli Lilly Crushes Q2 Estimates, Raises FY24 Guidance Amid Robust Drug Demand
Aug 08, 2024 ★★★★★
GuruFocus Research Drug Manufacturers
Aquestive Therapeutics Inc (AQST) Q2 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and Strategic Advancements
Company reports a 52% increase in total revenue and provides updated 2024 guidance amidst significant R&D and SG&A expenses. Aug 08, 2024
GuruFocus Research Drug Manufacturers
Curaleaf Holdings Inc (CURLF) Q2 2024 Earnings Call Transcript Highlights: Revenue Growth and Margin Improvements Amid Market Challenges
Curaleaf Holdings Inc (CURLF) reports a 2% revenue increase and significant margin improvements, despite facing market pressures and competition. Aug 08, 2024